158 related articles for article (PubMed ID: 1991849)
1. Insulin-like growth factor II-mediated proliferation of human neuroblastoma.
El-Badry OM; Helman LJ; Chatten J; Steinberg SM; Evans AE; Israel MA
J Clin Invest; 1991 Feb; 87(2):648-57. PubMed ID: 1991849
[TBL] [Abstract][Full Text] [Related]
2. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA
J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840
[TBL] [Abstract][Full Text] [Related]
3. Regulation of insulin-like growth factor-IL expression and its role in autocrine growth of human neuroblastoma cells.
Martin DM; Feldman EL
J Cell Physiol; 1993 May; 155(2):290-300. PubMed ID: 8482722
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
[TBL] [Abstract][Full Text] [Related]
6. Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.
Singer C; Rasmussen A; Smith HS; Lippman ME; Lynch HT; Cullen KJ
Cancer Res; 1995 Jun; 55(11):2448-54. PubMed ID: 7757999
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
8. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells.
Martin DM; Carlson RO; Feldman EL
J Neurosci Res; 1993 Apr; 34(5):489-501. PubMed ID: 8478984
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II mRNA expression in human breast cancer.
Yee D; Cullen KJ; Paik S; Perdue JF; Hampton B; Schwartz A; Lippman ME; Rosen N
Cancer Res; 1988 Dec; 48(23):6691-6. PubMed ID: 3180080
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
[TBL] [Abstract][Full Text] [Related]
12. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth.
Grellier P; De Galle B; Babajko S
Cancer Res; 1998 Apr; 58(8):1670-6. PubMed ID: 9563481
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-II (IGF-II) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine/paracrine role for IGF-II.
Han VK; Lu F; Bassett N; Yang KP; Delhanty PJ; Challis JR
Endocrinology; 1992 Dec; 131(6):3100-9. PubMed ID: 1446644
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.
Singleton JR; Randolph AE; Feldman EL
Cancer Res; 1996 Oct; 56(19):4522-9. PubMed ID: 8813151
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta (TGF-beta 1) and insulin-like growth factor II (IGF-II) messenger RNA in the developing subcutaneous tissue (SQ) of the fetal pig.
Richardson RL; Wright JT; Kim JW; Hausman GJ
Growth Dev Aging; 1992; 56(3):149-57. PubMed ID: 1428415
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.
El-Badry OM; Minniti C; Kohn EC; Houghton PJ; Daughaday WH; Helman LJ
Cell Growth Differ; 1990 Jul; 1(7):325-31. PubMed ID: 2177632
[TBL] [Abstract][Full Text] [Related]
19. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
